Alignment Healthcare to issue $330 million of 4.25% convertible notes due 2029
Alignment Healthcare entered into subscription agreements on November 14, 2024 to privately issue $330 million of 4.25% convertible senior notes due November 15, 2029, with closing expected on November 22, 2024. The company expects net proceeds of about $321.05 million, which it intends to use to repay its existing term loan, which bears interest at SOFR + 6.5%, and for general corporate purposes. The notes are convertible into common stock at an initial price of about $16.04 per share, a 25% premium to the November 14, 2024 closing price, so conversion could add shares outstanding.
Key points
- Principal: $330 million of 4.25% convertible senior notes due November 15, 2029, sold in a private placement
- Expected net cash proceeds: about $321.05 million, to repay the term loan (SOFR + 6.5%) and for general corporate purposes
- Initial conversion price: about $16.04 per share, a 25% premium to the November 14, 2024 closing price
- Expected closing: November 22, 2024, subject to customary closing conditions
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:58 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 15, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.